Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

64.50p
   
  • Change Today:
    -0.100p
  • 52 Week High: 64.80
  • 52 Week Low: 31.60
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 200,484
  • Market Cap: £348.66m
  • RiskGrade: 119
  • Beta: 0.01

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.
Registrars: Capita Registrars

Key Personnel

CEO: Nick Sedgwick
CFO: Andrew Franklin
Chairman: Camillo Pane
Chief Operating Officer: Jeyan Heper
Independent Non-Executive Director: Martin Sutherland
Independent Non-Executive Director: Kristof Neirynck
Senior Independent Director: Richard Jones
Non-Executive Dir: Eva-Lotta Sjöstedt, Richard McKenzie

Contact Details

Address: Avonbridge House, Bath Road, Chippenham, Wiltshire, United Kingdom, SN15 2BB
Phone: +44 (0)1249 466966
Fax: +44 (0)1249 466977
Website: http://www.alliancepharma.co.uk

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
ISIN: GB0031030819

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.50p
Change Today -0.100p
% Change -0.15 %
52 Week High 64.80
52 Week Low 31.60
Volume 200,484
Shares Issued 540.57m
Market Cap £348.66m
Beta 0.01
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.17% above the market average26.17% above the market average26.17% above the market average26.17% above the market average26.17% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average
Price Trend
72.91% above the market average72.91% above the market average72.91% above the market average72.91% above the market average72.91% above the market average
79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average
Income Not Available
Growth
49.41% below the market average49.41% below the market average49.41% below the market average49.41% below the market average49.41% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 09-May-2025

Time Volume / Share Price
16:35 46,790 @ 64.50p
16:35 1 @ 64.50p
16:35 1 @ 64.50p
16:35 1 @ 64.50p
16:35 1 @ 64.50p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page